Page last updated: 2024-09-03

27-hydroxycholesterol and Acute Relapsing Multiple Sclerosis

27-hydroxycholesterol has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Axelsson, M; Björkhem, I; Karrenbauer, VD; Lycke, J; Malmeström, C; Novakova, L; Zetterberg, H	1

Other Studies

1 other study(ies) available for 27-hydroxycholesterol and Acute Relapsing Multiple Sclerosis

Article	Year
Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis. Journal of the neurological sciences, 2015, Nov-15, Volume: 358, Issue:1-2 Topics: Adolescent; Adult; Biomarkers; Female; Humans; Hydroxycholesterols; Immunologic Factors; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Treatment Outcome; Young Adult	2015

Article

Year

Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.

Journal of the neurological sciences, 2015, Nov-15, Volume: 358, Issue:1-2

Topics: Adolescent; Adult; Biomarkers; Female; Humans; Hydroxycholesterols; Immunologic Factors; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Treatment Outcome; Young Adult

2015